Advanced search
1 file | 2.81 MB Add to list

Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants

(2022) VIRUSES-BASEL. 14(10).
Author
Organization
Project
Abstract
An adequate SARS-CoV-2 genomic surveillance strategy has proven to be essential for countries to obtain a thorough understanding of the variants and lineages being imported and successfully established within their borders. During 2020, genomic surveillance in Belgium was not structurally implemented but performed by individual research laboratories that had to acquire the necessary funds themselves to perform this important task. At the start of 2021, a nationwide genomic surveillance consortium was established in Belgium to markedly increase the country’s genomic sequencing efforts (both in terms of intensity and representativeness), to perform quality control among participating laboratories, and to enable coordination and collaboration of research projects and publications. We here discuss the genomic surveillance efforts in Belgium before and after the establishment of its genomic sequencing consortium, provide an overview of the specifics of the consortium, and explore more details regarding the scientific studies that have been published as a result of the increased number of Belgian SARS-CoV-2 genomes that have become available.
Keywords
Virology, Infectious Diseases, SARS-CoV-2, COVID-19, Belgium, genomic surveillance, next-generation sequencing, variants of concern

Downloads

  • viruses-14-02301.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 2.81 MB

Citation

Please use this url to cite or link to this publication:

MLA
Cuypers, Lize, et al. “Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants.” VIRUSES-BASEL, vol. 14, no. 10, 2022, doi:10.3390/v14102301.
APA
Cuypers, L., Dellicour, S., Hong, S. L., Potter, B. I., Verhasselt, B., Vereecke, N., … Baele, G. (2022). Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants. VIRUSES-BASEL, 14(10). https://doi.org/10.3390/v14102301
Chicago author-date
Cuypers, Lize, Simon Dellicour, Samuel L. Hong, Barney I. Potter, Bruno Verhasselt, Nick Vereecke, Laurens Lambrechts, et al. 2022. “Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants.” VIRUSES-BASEL 14 (10). https://doi.org/10.3390/v14102301.
Chicago author-date (all authors)
Cuypers, Lize, Simon Dellicour, Samuel L. Hong, Barney I. Potter, Bruno Verhasselt, Nick Vereecke, Laurens Lambrechts, Keith Durkin, Vincent Bours, Sofieke Klamer, Guillaume Bayon-Vicente, Carl Vael, Kevin K. Ariën, Ricardo De Mendonca, Oriane Soetens, Charlotte Michel, Bertrand Bearzatto, Reinout Naesens, Jeremie Gras, Anne Vankeerberghen, Veerle Matheeussen, Geert Martens, Dagmar Obbels, Ann Lemmens, Bea Van den Poel, Ellen Van Even, Klara De Rauw, Luc Waumans, Marijke Reynders, Jonathan Degosserie, Piet Maes, Emmanuel André, and Guy Baele. 2022. “Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants.” VIRUSES-BASEL 14 (10). doi:10.3390/v14102301.
Vancouver
1.
Cuypers L, Dellicour S, Hong SL, Potter BI, Verhasselt B, Vereecke N, et al. Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants. VIRUSES-BASEL. 2022;14(10).
IEEE
[1]
L. Cuypers et al., “Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants,” VIRUSES-BASEL, vol. 14, no. 10, 2022.
@article{8770824,
  abstract     = {{An adequate SARS-CoV-2 genomic surveillance strategy has proven to be essential for countries to obtain a thorough understanding of the variants and lineages being imported and successfully established within their borders. During 2020, genomic surveillance in Belgium was not structurally implemented but performed by individual research laboratories that had to acquire the necessary funds themselves to perform this important task. At the start of 2021, a nationwide genomic surveillance consortium was established in Belgium to markedly increase the country’s genomic sequencing efforts (both in terms of intensity and representativeness), to perform quality control among participating laboratories, and to enable coordination and collaboration of research projects and publications. We here discuss the genomic surveillance efforts in Belgium before and after the establishment of its genomic sequencing consortium, provide an overview of the specifics of the consortium, and explore more details regarding the scientific studies that have been published as a result of the increased number of Belgian SARS-CoV-2 genomes that have become available.}},
  articleno    = {{2301}},
  author       = {{Cuypers, Lize and Dellicour, Simon and Hong, Samuel L. and Potter, Barney I. and Verhasselt, Bruno and Vereecke, Nick and Lambrechts, Laurens and Durkin, Keith and Bours, Vincent and Klamer, Sofieke and Bayon-Vicente, Guillaume and Vael, Carl and Ariën, Kevin K. and De Mendonca, Ricardo and Soetens, Oriane and Michel, Charlotte and Bearzatto, Bertrand and Naesens, Reinout and Gras, Jeremie and Vankeerberghen, Anne and Matheeussen, Veerle and Martens, Geert and Obbels, Dagmar and Lemmens, Ann and Van den Poel, Bea and Van Even, Ellen and De Rauw, Klara and Waumans, Luc and Reynders, Marijke and Degosserie, Jonathan and Maes, Piet and André, Emmanuel and Baele, Guy}},
  issn         = {{1999-4915}},
  journal      = {{VIRUSES-BASEL}},
  keywords     = {{Virology,Infectious Diseases,SARS-CoV-2,COVID-19,Belgium,genomic surveillance,next-generation sequencing,variants of concern}},
  language     = {{eng}},
  number       = {{10}},
  pages        = {{19}},
  title        = {{Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants}},
  url          = {{http://doi.org/10.3390/v14102301}},
  volume       = {{14}},
  year         = {{2022}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: